Applied DNA Sciences manufactures linear deoxyribonucleic acid (DNA) for use in its proprietary products as well as for sale to third parties. Co. manufactures non-biological DNA-based molecular taggants for use in its proprietary supply chain security, anticounterfeiting, brand protection and law enforcement products. Through its subsidiary, LineaRx, Inc., Co. supplies polymerase chain reaction produced linear DNA for use in preclinical biotherapeutic applications including CAR T/TCR, RNA manufacture, DNA-based vaccines and gene therapies, as well as in vitro diagnostics. We show 27 historical shares outstanding datapoints in our coverage of APDN's shares outstanding history.
Understanding the changing numbers of APDN shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like APDN versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching APDN by allowing them to research APDN shares outstanding history
as well as any other stock in our coverage universe. |
Video: Shares Outstanding Importance
